Form 4: NEXGEL Director Jerome B. Zeldis Acquires Shares and Warrants in Registered Direct Offering

Director Jerome B. Zeldis increased his holdings in NEXGEL, Inc. through a purchase of common stock and warrants as part of a registered direct offering.

Summary

• On August 23, 2024, Jerome B. Zeldis, a director of NEXGEL, Inc., acquired 10,000 shares of common stock at a price of $2.50 per share.
• The director also acquired a warrant to purchase 5,000 shares of common stock with an exercise price of $4.25, exercisable from August 23, 2024, until August 23, 2029.
• These acquisitions were made in connection with NEXGEL's registered direct offering.
• Following the transaction, Zeldis directly owns 103,028 shares of NEXGEL common stock and warrants for 5,000 shares.
• Zeldis has agreed to a 180-day lock-up period, preventing him from selling or disposing of the acquired shares and underlying warrant shares until after August 23, 2024.

Sentiment

Score: 6

Explanation: Director's investment is a positive signal, but the offering itself may indicate a need for capital. The lock-up period adds a layer of complexity.

Positives

• The director's purchase of shares and warrants signals confidence in the company's future prospects.
• The registered direct offering provides NEXGEL with additional capital.

Risks

• The lock-up agreement prevents the director from selling the shares for 180 days, which could create selling pressure if a large block of shares becomes available at once.

Future Outlook

The document does not contain specific forward-looking statements beyond the lock-up agreement.

Industry Context

Registered direct offerings are a common method for small-cap companies like NEXGEL to raise capital. Director participation can be viewed positively by investors.

Stakeholder Impact

• Shareholders may view the director's purchase as a positive sign.
• The capital raised through the offering could support the company's operations and growth.

Key Dates